MedPath

Prospective minimally interventional clinical trial of the Prostate Cancer Decision Aid to determine the reduction of decisional conflict and the strengthening of health literacy in patients with newly diagnosed, locally treatable prostate cancer

Phase 4
Recruiting
Conditions
Malignant neoplasm of prostate
C61
Registration Number
DRKS00034308
Lead Sponsor
Philipps-Universität Marburg, Klinik für Urologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
500
Inclusion Criteria

Histologically confirmed prostate carcinoma before the start of primary therapy
- Age >18 years
- Proficiency in the German language
- Consent to participate in the study
- Ability to use a digital device with at least one relative
- Internet access and e-mail address available

Exclusion Criteria

- Age < 18 years
- Patients not able to give consent
- Patients under legal care

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of the decisional conflict (score of the Decisional Conflict Scale) by 12.5 points
Secondary Outcome Measures
NameTimeMethod
- Patient knowledge about prostate cancer (score of the test to assess the level of knowledge about prostate cancer)<br>- Emotional stress (score of the distress thermometer)<br>- Patient preference (questionnaire - What can you imagine? - multiple choice)<br>- Usability of the Prostate cancer decision aid<br>- Recording of possible side effects and risks
© Copyright 2025. All Rights Reserved by MedPath